JP2005508855A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508855A5
JP2005508855A5 JP2002589487A JP2002589487A JP2005508855A5 JP 2005508855 A5 JP2005508855 A5 JP 2005508855A5 JP 2002589487 A JP2002589487 A JP 2002589487A JP 2002589487 A JP2002589487 A JP 2002589487A JP 2005508855 A5 JP2005508855 A5 JP 2005508855A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
substituted
pyrimidine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002589487A
Other languages
English (en)
Japanese (ja)
Other versions
JP4155827B2 (ja
JP2005508855A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/005241 external-priority patent/WO2002092603A1/en
Publication of JP2005508855A publication Critical patent/JP2005508855A/ja
Publication of JP2005508855A5 publication Critical patent/JP2005508855A5/ja
Application granted granted Critical
Publication of JP4155827B2 publication Critical patent/JP4155827B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002589487A 2001-05-14 2002-05-13 オキサゾロ−およびフロピリミジンならびに腫瘍に対する医薬としてのその使用 Expired - Fee Related JP4155827B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH8732001 2001-05-14
PCT/EP2002/005241 WO2002092603A1 (en) 2001-05-14 2002-05-13 Oxazolo-and furopyrimidines and their use in medicaments against tumors

Publications (3)

Publication Number Publication Date
JP2005508855A JP2005508855A (ja) 2005-04-07
JP2005508855A5 true JP2005508855A5 (cg-RX-API-DMAC10.html) 2005-07-28
JP4155827B2 JP4155827B2 (ja) 2008-09-24

Family

ID=4544205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002589487A Expired - Fee Related JP4155827B2 (ja) 2001-05-14 2002-05-13 オキサゾロ−およびフロピリミジンならびに腫瘍に対する医薬としてのその使用

Country Status (12)

Country Link
US (1) US7294633B2 (cg-RX-API-DMAC10.html)
EP (1) EP1390371B1 (cg-RX-API-DMAC10.html)
JP (1) JP4155827B2 (cg-RX-API-DMAC10.html)
CN (1) CN100378107C (cg-RX-API-DMAC10.html)
AT (1) ATE319718T1 (cg-RX-API-DMAC10.html)
BR (1) BR0209645A (cg-RX-API-DMAC10.html)
CA (1) CA2449188A1 (cg-RX-API-DMAC10.html)
DE (1) DE60209721T2 (cg-RX-API-DMAC10.html)
DK (1) DK1390371T3 (cg-RX-API-DMAC10.html)
ES (1) ES2259707T3 (cg-RX-API-DMAC10.html)
PT (1) PT1390371E (cg-RX-API-DMAC10.html)
WO (1) WO2002092603A1 (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689753A4 (en) * 2003-12-04 2010-07-07 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ddr2 티로신키나아제 활성 저해제
JPWO2005095419A1 (ja) * 2004-04-01 2008-02-21 武田薬品工業株式会社 チアゾロピリミジン誘導体
EP1874769B1 (de) 2005-04-25 2011-09-14 Merck Patent GmbH Neuartige aza-heterozyklen als kinase-inhibitoren
DE102005061170A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
DE102005061171A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
EP3219319A1 (en) * 2006-06-22 2017-09-20 Nippon Chemiphar Co., Ltd. Agent for overcoming resistance to anti-cancer agent
DE102007019691A1 (de) 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007019690A1 (de) 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
RU2345996C1 (ru) * 2007-07-17 2009-02-10 Андрей Александрович Иващенко Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
EP2318415B1 (en) * 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
UY32240A (es) 2008-11-14 2010-06-30 Boeringer Ingelheim Kg Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
CN101899057A (zh) * 2010-07-21 2010-12-01 中国药科大学 嘧啶并噁唑衍生物的一种制备方法及其在医学上的用途
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
US8580816B2 (en) * 2011-07-07 2013-11-12 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
CN103087077B (zh) * 2011-11-03 2016-05-18 上海希迈医药科技有限公司 噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
CN103360407B (zh) * 2012-04-10 2016-06-22 上海希迈医药科技有限公司 一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
WO2015162518A1 (en) 2014-04-25 2015-10-29 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
CN104650111A (zh) * 2015-01-14 2015-05-27 中国药科大学 芳基脲及芳基酰胺取代的噁唑并嘧啶类化合物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137879A (en) 1990-03-30 1992-08-11 Dowelanco Furopyrimidin-4-imine derivatives
US5227387A (en) * 1991-09-03 1993-07-13 Dowelanco Quinoline nematicidal method
ES2109796T3 (es) 1994-05-03 1998-01-16 Ciba Geigy Ag Derivados de pirrolopirimidilo con efecto antiproliferante.
JPH1184248A (ja) * 1997-09-12 1999-03-26 Nikon Corp 反射屈折縮小光学系
KR100600550B1 (ko) * 2000-10-20 2006-07-13 에자이 가부시키가이샤 질소 함유 방향환 유도체

Similar Documents

Publication Publication Date Title
JP5326092B2 (ja) 高増殖性疾患及び血管形成関連疾患の治療に有用な置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン誘導体
US6432989B1 (en) Use of CRF antagonists to treat circadian rhythm disorders
RU2331644C2 (ru) Пирролопиримидины, обладающие свойствами ингибитора катепсина к, и способ их получения (варианты)
JP2007522200A5 (cg-RX-API-DMAC10.html)
AU2011328192B2 (en) Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
JP2021525783A5 (cg-RX-API-DMAC10.html)
JP2008519790A5 (cg-RX-API-DMAC10.html)
RU2006129307A (ru) Терапевтические комбинации атипичных нейролептиков с антагонистами кортикотропин-рилизинг фактора
RU2005102917A (ru) Ингибиторы тирозинкиназ
RU2005117383A (ru) Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета
CA2473026A1 (en) 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
JP2013509438A5 (cg-RX-API-DMAC10.html)
IL156609A (en) Pyrazolo [1, a5] Pyrimidines compressed by cyclocalyptic or heterocyclic rings and repellents containing them
RU2009127842A (ru) ПРОИЗВОДНЫЕ 5,6,7,8-ТЕТРАГИДРОИМИДАЗО[1.5-а]ПИРАЗИНА
MXPA05008584A (es) Compuestos heterociclicos utiles como activadores de nurr-1.
ATE328886T1 (de) Substituierte pyrazolo- und thiazolopyrimidine als analgetika
RU2014126750A (ru) Ингибиторы тирозинкиназы брутона
JP2011509307A5 (cg-RX-API-DMAC10.html)
WO2012062743A1 (en) Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
US9730943B2 (en) Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolines
PE20061193A1 (es) DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
RU2007106552A (ru) Конденсированные пиримидоны, пригодные для лечения и предотвращения злокачественного новообразования
AU2024356662A1 (en) Combination therapies including myt1 inhibitors and wee1 inhibitors
JP2007501210A5 (cg-RX-API-DMAC10.html)
ATE309246T1 (de) 1-(alkyl), 1-(heteroaryl)alkyl und 1-(aryl)alkyl)-7-(pyrimidin-4-yl)-imidazo(1,2-a pyrimidin-5(h)- one derivate